Discovery of 2,3-Dihydro[1,4]dioxino[2,3-

Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
29 Mar 2024
Historique:
medline: 29 3 2024
pubmed: 29 3 2024
entrez: 29 3 2024
Statut: aheadofprint

Résumé

Patients with arterial embolic disease have benefited greatly from antiplatelet therapy. However, hemorrhage risk of antiplatelet agents cannot be ignored. Herein, we describe the discovery of 2,3-dihydro[1,4]dioxino[2,3-

Identifiants

DOI: 10.1021/acs.jmedchem.3c02099 PMID: 38552183
pubmed: 38552183
doi: 10.1021/acs.jmedchem.3c02099
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Panpan Chen (P)

Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.

Cai Chen (C)

Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.

Yizheng Zheng (Y)

School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.

Fangjun Chen (F)

Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.

Zhaojun Liu (Z)

School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.

Shenhong Ren (S)

School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.

Hangyu Song (H)

Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.

Tongdan Liu (T)

School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.

Zhipeng Lu (Z)

School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.

Hongbin Sun (H)

Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
Chongqing Innovation Institute of China Pharmaceutical University, Chongqing 401135, China.
ORCID: 0000-0002-3452-7674

Yi Kong (Y)

School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
ORCID: 0000-0002-2329-7009

Haoliang Yuan (H)

Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
Chongqing Innovation Institute of China Pharmaceutical University, Chongqing 401135, China.
ORCID: 0000-0003-0248-4347

Classifications MeSH